Blog

WannaCry ransomware infected Bayer U.S. medical devices

The WannaCry ransomware attack that took out the United Kingdom Healthcare Service (UKHS) also hit at least two Bayer medical devices in the U.S., Forbes reports.  An image received by the business magazine shows the now-familiar WannaCry ransom message obscuring the display of a Bayer radiology system.

Limited domestic vaccine manufacturing endangers U.S. flu prep, GAO report says

The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drug maker has a U.S. facility with egg-based vaccine production capabilities.  Furthermore, the situation could be even more serious if the epidemic comes from an Avian Flu, which could infect the very same hens that supply the eggs used for vaccine development.

Diabetes drug Metformin shows promise in treating one form of autism

Metformin has been helping patients with Type 2 diabetes control their blood sugar for more than two decades; however, now researchers led by McGill University are investigating a new use for the drug:  to treat fragile X syndrome, which causes some forms of autism.

Cyberattack rocks U.K. NHS, forcing care cancellations

The healthcare system in the United Kingdom is reeling from a ransomware attack.  The spread of the program across National Health Service (NHS) computers forced doctors to switch to pen and paper and continued to affect care days after it initially hit.

EMA to Pharma Companies: Prepare for UK to EU Shift

Setting the stage for a likely exodus from the UK for pharmaceutical manufacturers and staff, the European Medicines Agency (EMA) in May notified marketing authorization holders (MAHs) that for centrally authorized products, EU law requires them to be established in the EU or European Economic Area, which includes Iceland, Liechtenstein and Norway.

‘Priming’ protein boosts stem cell response to injury, promotes healing

Stanford University scientists have identified a protein that, given before an injury, boosts stem cell response and improves healing.  “Priming” with this protein, called hepatocyte growth factor activator (HGFA), could eventually speed recovery in cases where injury is expected, such as patients undergoing surgery.